We are live on ! Find out more
CRVS icon

Corvus Pharmaceuticals

52 hedge funds and large institutions have $360M invested in Corvus Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

44% more capital invested

Capital invested by funds: $250M → $360M (+$110M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.79% less ownership

Funds ownership: 83.62%82.82% (-0.79%)

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

2% less funds holding

Funds holding: 5352 (-1)

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
16
Reduced
17
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$2K -$642 -41 -26%
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$125 -$580 -37 -86%
LTFS
53
Ladenburg Thalmann Financial Services
Florida
-$220K -15,350 Closed
Goldman Sachs
54
Goldman Sachs
New York
-$173K -12,110 Closed
TRCT
55
Tower Research Capital (TRC)
New York
-$21K -1,427 Closed
CMBA
56
C.M. Bidwell & Associates
Hawaii
-$3K -234 Closed